NIH #P01CA129243
Targets for Therapy for Carcinomas of the Lung
Active
- Amount
- $2M–$3M
- Period
- 2007-07-01 → 2031-04-30
- PIs
- 2
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Alexander Drilon
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index93
i10-index296
Publications1,443
Citations39,791
Grants
5 total · 2 active
NIH #R01CA273224
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Active
- Amount
- $700K–$800K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #R01CA251591
Predicting sensitivity and resistance in RET-driven cancers
- Amount
- $400K–$500K
- Period
- 2021-04-01 → 2026-03-31
- PIs
- 1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Supplementary Data1 from Retreatment with First-Generation Selective RET Inhibitors in <i>RET</i>-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry2026-07-01
- New NIH award: Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy2022-07-01
- New NIH award: Targets for Therapy for Carcinomas of the Lung2007-07-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-01
Data may not be current
Find elsewhere
ORCID: 0000-0001-6806-9061